Back to results
US 2021/0267958 A1Published application
Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder
AssigneeThe Children's Hospital of Philadelphia
InventorsHakon Hakonarson, Charlly Kao
Life of this patent
Estimating the term…
Abstract
This application relates to methods of diagnosing and treating anorexia nervosa (AN) and binge eating disorder (BED) with a nonselective activator of metabotropic glutamate receptors (mGluRs).
Claims20
-111. (canceled)
A method of treating an eating disorder in a subject comprising administering a nonselective mGluR activator to the subject, wherein the eating disorder is selected from anorexia nervosa (AN) and binge eating disorder (BED), thereby treating AN and/or BED.
Dependencies are inferred from the claim text.